Published in Neurology on September 02, 2008
Neuromuscular imaging in inherited muscle diseases. Eur Radiol (2010) 1.79
Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest (2009) 1.63
Desminopathies: pathology and mechanisms. Acta Neuropathol (2012) 1.17
Pathophysiology of protein aggregation and extended phenotyping in filaminopathy. Brain (2012) 1.12
Quantitative MRI can detect subclinical disease progression in muscular dystrophy. J Neurol (2012) 1.03
Comparison of clinical semi-quantitative assessment of muscle fat infiltration with quantitative assessment using chemical shift-based water/fat separation in MR studies of the calf of post-menopausal women. Eur Radiol (2012) 0.95
A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients. Mol Cell Proteomics (2012) 0.93
Filamin C-related myopathies: pathology and mechanisms. Acta Neuropathol (2012) 0.93
Muscle imaging findings in GNE myopathy. J Neurol (2012) 0.90
Myofibrillar myopathies: new developments. Curr Opin Neurol (2013) 0.89
Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy. J Neurol (2011) 0.85
Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscul Disord (2013) 0.85
Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia. Muscle Nerve (2012) 0.84
Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies. Orphanet J Rare Dis (2014) 0.84
Congenital myopathy caused by a novel missense mutation in the CFL2 gene. Neuromuscul Disord (2012) 0.83
Muscle MRI in muscular dystrophies. Acta Myol (2015) 0.80
A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A). J Neurol (2011) 0.80
Clinical and muscle imaging findings in 14 mainland chinese patients with oculopharyngodistal myopathy. PLoS One (2015) 0.79
Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review). Mol Med Rep (2014) 0.78
RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice. Mol Ther Nucleic Acids (2014) 0.78
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy. J Cardiovasc Magn Reson (2010) 0.78
Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function. PLoS One (2016) 0.77
Muscle magnetic resonance imaging in congenital myasthenic syndromes. Muscle Nerve (2016) 0.77
Functional characterization of a GFAP variant of uncertain significance in an Alexander disease case within the setting of an individualized medicine clinic. Clin Case Rep (2016) 0.76
Imaging alterations in skeletal muscle channelopathies: a study in 15 patients. Acta Myol (2015) 0.75
Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches. J Neuromuscul Dis (2017) 0.75
Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1. PLoS One (2015) 0.75
Limb girdle muscular dystrophy type 2G with myopathic-neurogenic motor unit potentials and a novel muscle image pattern. BMC Clin Pathol (2014) 0.75
Muscle MRI findings in facioscapulohumeral muscular dystrophy. Eur Radiol (2015) 0.75
Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report. Biomed Rep (2017) 0.75
Muscle MRI in neutral lipid storage disease (NLSD). J Neurol (2017) 0.75
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Mutations in myotilin cause myofibrillar myopathy. Neurology (2004) 2.41
Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet (1998) 2.17
A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet (2005) 1.95
Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain (2006) 1.88
Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol (2005) 1.80
Desmin myopathy. Brain (2004) 1.79
Zaspopathy in a large classic late-onset distal myopathy family. Brain (2007) 1.47
Myotilinopathy: refining the clinical and myopathological phenotype. Brain (2005) 1.37
Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene. Neuromuscul Disord (2007) 1.35
Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol (1996) 1.27
Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain (2007) 1.26
Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain (2007) 1.25
Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol (1996) 1.22
Computed tomography of the human skeletal muscular system. Neuroradiology (1979) 1.18
Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat (2006) 1.14
On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet (2003) 1.13
Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord (2004) 1.10
Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol (2005) 1.08
Myofibrillar myopathy. Ann Neurol (1999) 1.07
Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Genet (2005) 1.06
A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol (2004) 1.03
Computed tomographic patterns of muscles in neuromuscular diseases. Arch Neurol (1984) 1.02
Hsp27-2D-gel electrophoresis is a diagnostic tool to differentiate primary desminopathies from myofibrillar myopathies. FEBS Lett (2005) 1.00
Desmin-related myopathies. Curr Opin Neurol (1997) 0.96
myotilin Mutation found in second pedigree with LGMD1A. Am J Hum Genet (2002) 0.94
The enlarging spectrum of desminopathies: new morphological findings, eastward geographic spread, novel exon 3 desmin mutation. Acta Neuropathol (2005) 0.93
Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet (2003) 0.93
Desmin-related myopathies in mice and man. Acta Physiol Scand (2001) 0.92
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype. J Neurol Neurosurg Psychiatry (2007) 0.91
Differences in the distribution of synemin, paranemin, and plectin in skeletal muscles of wild-type and desmin knock-out mice. Histochem Cell Biol (2000) 0.91
[Familial myopathy with desmin storage seen as a granulo-filamentar, electron-dense material with mutation of the alphaB-cristallin gene]. Rev Neurol (Paris) (2000) 0.90
Different early pathogenesis in myotilinopathy compared to primary desminopathy. Neuromuscul Disord (2006) 0.86
Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene. Neurology (2006) 0.83
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science (2001) 7.34
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Breast tumor cell lines from pleural effusions. J Natl Cancer Inst (1974) 5.39
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell (2000) 5.31
Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MAT alpha 2 repressor. Cell (1993) 5.05
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet (1999) 5.04
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro (1978) 4.67
Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature (1997) 4.40
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet (1998) 4.38
Role of Cue1p in ubiquitination and degradation at the ER surface. Science (1997) 4.18
Environment and development. Earth system science for global sustainability: grand challenges. Science (2010) 3.92
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84
Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature (1990) 3.77
A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat Cell Biol (2000) 3.65
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet (1998) 3.62
Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology (2001) 3.27
Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med (1993) 3.15
Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J Immunol (1986) 3.08
Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet (1995) 3.05
Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med (2001) 2.94
An iron-regulated ferric reductase associated with the absorption of dietary iron. Science (2001) 2.90
Evolutionary conservation of components of the protein translocation complex. Nature (1994) 2.77
Ubiquitin-conjugating enzymes: novel regulators of eukaryotic cells. Trends Biochem Sci (1990) 2.74
Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway. EMBO J (1996) 2.72
Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology (2003) 2.70
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol (2008) 2.57
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57
Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation (1983) 2.51
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell (2001) 2.45
Screening for mental health: validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard. Psychiatry Res (2001) 2.42
Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet (2001) 2.39
Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings. Lancet (2003) 2.38
The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med (1997) 2.28
Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci U S A (1999) 2.27
Redesign of PCR primers for mitochondrial cytochrome c oxidase subunit I for marine invertebrates and application in all-taxa biotic surveys. Mol Ecol Resour (2013) 2.27
Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III (1994) 2.22
Factors influencing remission from alcohol dependence without formal help in a representative population sample. Addiction (2001) 2.22
Molecular evidence that the asexual industrial fungus Trichoderma reesei is a clonal derivative of the ascomycete Hypocrea jecorina. Proc Natl Acad Sci U S A (1996) 2.21
Clinical evaluation of a Mycobacterium tuberculosis PCR assay. J Clin Microbiol (1995) 2.19
Randomized clinical trial of self-gripping mesh versus sutured mesh for Lichtenstein hernia repair. Br J Surg (2012) 2.16
Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology (2000) 2.16
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol (2008) 2.12
MHC class I-restricted CTL responses to exogenous antigens. Immunity (1996) 2.12
Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol (2001) 2.08
Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy. Br J Haematol (1997) 2.08
Volumetric spectroscopic imaging with spiral-based k-space trajectories. Magn Reson Med (1998) 2.05
Cloning of DNA fragments complementary to tobacco nitrate reductase mRNA and encoding epitopes common to the nitrate reductases from higher plants. Mol Gen Genet (1987) 2.05
Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Respir J (2005) 2.04
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care (2001) 2.02
Well-established nucleon resonances revisited by double-polarization measurements. Phys Rev Lett (2012) 1.99
The human gene for alkaptonuria (AKU) maps to chromosome 3q. Genomics (1994) 1.99
Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med (1999) 1.94
A second trimeric complex containing homologs of the Sec61p complex functions in protein transport across the ER membrane of S. cerevisiae. EMBO J (1996) 1.93
Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain (2001) 1.91
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A (2001) 1.90
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol (2009) 1.90
POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology (2004) 1.89
Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol (2000) 1.84
THE ADVISABILITY OF TOTALLY EXCISING BOTH PECTORAL MUSCLES IN THE RADICAL OPERATION FOR CANCER OF THE BREAST. Ann Surg (1918) 1.84
Expression of the potato tuber ADP-glucose pyrophosphorylase in Escherichia coli. J Biol Chem (1993) 1.83
Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet (2001) 1.83
The central nervous system and carbon monoxide poisoning. II. Anatomical study of brain lesions following intoxication with carbon monixide (22 cases). Prog Brain Res (1967) 1.80
Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology (1997) 1.79
Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation (1999) 1.78
A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int (1982) 1.78
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol (2010) 1.75
Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord (1991) 1.75
Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol (1999) 1.75
The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr Probl Dermatol (1978) 1.74
Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol (2001) 1.73
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J (1999) 1.73
Three-dimensional reconstruction with contrast transfer function correction from energy-filtered cryoelectron micrographs: procedure and application to the 70S Escherichia coli ribosome. J Struct Biol (1997) 1.72
MTM1 mutations in X-linked myotubular myopathy. Hum Mutat (2000) 1.72
Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry (2009) 1.70
Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature (1992) 1.70
Signal transduction through CD4 receptors: stimulatory vs. inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor. Eur J Immunol (1988) 1.68
Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses (1994) 1.67
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Nitrate, a signal relieving seed dormancy in Arabidopsis. Plant Cell Environ (2005) 1.66
Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord (1991) 1.65
Comparison between sheep and human cervical spines: an anatomic, radiographic, bone mineral density, and biomechanical study. Spine (Phila Pa 1976) (2001) 1.65
Studies on natural recovery from alcohol dependence: sample selection bias by media solicitation? Addiction (2000) 1.65
Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J Cell Biol (1998) 1.65
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Polyneuropathy after perhexiline maleate therapy. Br Med J (1976) 1.64
Early embryonic death of mice deficient in gamma-adaptin. J Biol Chem (1999) 1.64
Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J Clin Microbiol (1996) 1.63
Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of Thrombolysis. J Am Coll Cardiol (1998) 1.63
Premutation allele pool in myotonic dystrophy type 2. Neurology (2008) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Linkage of proximal myotonic myopathy to chromosome 3q. Neurology (1999) 1.60
Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology (2001) 1.60
High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol (2000) 1.58